Home Blood Disorders

Blood Disorders

Latest
Blood Disorders

AbbVie, Lupin to Develop MALT1 Inhibitors for Blood Cancers in $977M+...

Blood Disorders

Celgene, Dragonfly Expand Cancer Immunotherapy Collaboration

Blood Disorders

Lilly, NextCure Launch Cancer Immunotherapy Partnership

Spark Therapeutics saw its share price tumble about 30% in early-morning trading after it reported mixed preliminary data this morning from a Phase I/II trial of its hemophilia A gene therapy candidate SPK-8001. [Source: wildpixel/Getty Images]
Blood Disorders

Spark Therapeutics Stock Tumbles after Mixed Results from Phase I/II Trial...

Leukemia Blood Cell [Kateryna Kon/Science Photo Library/Getty Images]
Blood Disorders

Leukemia Cells Take the Fast Track to the Nervous System

Scanning electron microscopy images confirm the deposition of an extracellular matrix which embeds cells
Blood Disorders

Artificial Bone Marrow Supports Blood Stem Cells for Disease Modelling and...

(Left two panels) Hepatocyte-like cells (HLCs) differentiated from the stem cells of patients with hemophilia B show very low levels of clotting factor IX
Blood Disorders

CRISPR “One Shot” Cell Therapy for Hemophilia Developed

Scientists say CRISPR could be used to exploit naturally occurring mutations as treatments for blood diseases such as beta-thalassemia and sickle cell disease. [Creative Commons EM Unit
Blood Disorders

CRISPR Use Could Lead to “Organic” Gene Therapies for Blood Disorders

Daiichi Sankyo U.S. headquarters in Basking Ridge
Blood Disorders

Daiichi Sankyo Eliminates 280 U.S. Jobs

Blood Disorders

Redosable Gene-Therapy Developer Generation Bio Wins $100M Series B Financing

Load more

Recently Featured

Stay Connected

556,812FansLike
47,177FollowersFollow
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up